What Researchers Did
Researchers used a pretest-posttest design to evaluate changes in pelvic late radiation tissue injuries (LRTIs) and health-related quality of life (HRQoL) in cancer survivors after hyperbaric oxygen therapy.
What They Found
Among 95 participants, scores for urinary and bowel symptoms, overall health-related quality of life, and several symptom scales (sleep, diarrhea, pain, fatigue) significantly improved six months after hyperbaric oxygen therapy (P-range = 0.00-0.04). These improvements were observed immediately after treatment and maintained or further improved at the six-month follow-up. A weak but significant correlation was found between changes in symptoms and overall HRQoL (Pearson r-range 0.20-0.27).
What This Means for Canadian Patients
Cancer survivors experiencing pelvic LRTIs and impaired HRQoL may benefit from considering hyperbaric oxygen therapy. This treatment could offer practical relief from debilitating symptoms like urinary and bowel issues, pain, and fatigue, potentially enhancing their overall quality of life.
Canadian Relevance
This study did not report any specific Canadian connection or participation.
Study Limitations
A limitation of this study is the pretest-posttest design without a control group, which limits the ability to attribute improvements solely to the intervention.